JFD01307SC

CAS No. 51070-56-5

JFD01307SC ( [(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)AMINO] )

Catalog No. M24475 CAS No. 51070-56-5

JFD01307SC is a glutamine synthetase inhibitor. It is anti-tuberculosis agent and acts as a mimic of L-Glutamate and thus target enzymes involved in glutamine biosynthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 In Stock
25MG 65 In Stock
50MG 110 In Stock
100MG 177 In Stock
200MG 267 In Stock
500MG 464 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JFD01307SC
  • Note
    Research use only, not for human use.
  • Brief Description
    JFD01307SC is a glutamine synthetase inhibitor. It is anti-tuberculosis agent and acts as a mimic of L-Glutamate and thus target enzymes involved in glutamine biosynthesis.
  • Description
    JFD01307SC is a glutamine synthetase inhibitor. It is anti-tuberculosis agent and acts as a mimic of L-Glutamate and thus target enzymes involved in glutamine biosynthesis.
  • Synonyms
    [(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)AMINO]
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    51070-56-5
  • Formula Weight
    193.2
  • Molecular Formula
    C6H11NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:2 mg/mL?(10.35 mM;?ultrasonic and warming and heat to 80°C)
  • SMILES
    O=C(O)CNC(CC1)CS1(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gyanu Lamichhane, et al. Essential metabolites of Mycobacterium tuberculosis and their mimics. mBio. 2011 Feb 1;2(1):e00301-10.
molnova catalog
related products
  • Nacubactam

    Nacubactam (OP 0595, RG 6080, RO 7079901) is a diazabicyclooctane that inhibits class A and C β-lactamases with IC50 of <1 uM.

  • CysHHC10

    CysHHC10 is a synthetic antimicrobial peptide (AMP), and exhibits strong anti-microbial properties against both Gram-positive and Gram-negative bacteria.

  • Besifloxacin hydroch...

    A fourth-generation fluoroquinolone antibiotic that exhibits a broad spectrum in vitro activity against a wide range of Gram-positive and Gram-negative ocular pathogens.